MDA ALS Division Co-Chair Augie Nieto, who received an ALS diagnosis in 2005, participated in the clinical trial of the device that led to FDA approval. In the summer of 2011, Nieto underwent a tracheostomy and switched to invasive ventilation.
"Getting this device was one of the best decisions I’ve made since my diagnosis," Nieto said. "It helped me delay the need for a tracheostomy for more than six years after my diagnosis. Most people with ALS ultimately will face a decision about going on a vent. The pacer will help extend that decision while we help find a cure."
About breathing difficulties in ALS...
Editor's note: This story was updated Oct. 28, 2011, to reflect that the FDA approved the NeuRx Diaphragm Pacing System as a humanitarian use device.